Pasithea Therapeutics Corp. (KTTA) Stock Ticker
Market factors today
Unlock the full KTTA picture
About Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.
KTTA stock facts
| Ticker symbol | KTTA |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $16.7M |
| CEO | Tiago Reis Marques |
| Employees | 5 |
| Headquarters | Miami Beach, FL, US |
| IPO date | 2021-09-15 |
| Website | www.pasithea.com |
What you can see for KTTA on Tickr
Live KTTA price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the KTTA report.
Rankings
FAQ
What is the ticker symbol for Pasithea Therapeutics Corp.?
The ticker symbol for Pasithea Therapeutics Corp. is KTTA, listed on the NASDAQ Capital Market.
What is KTTA?
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained…